11-44124982-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 16P and 4B. PVS1PP5_Very_StrongBS2
The NM_207122.2(EXT2):c.937C>T(p.Gln313*) variant causes a stop gained, splice region change. The variant allele was found at a frequency of 0.00000411 in 1,460,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_207122.2 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXT2 | NM_207122.2 | c.937C>T | p.Gln313* | stop_gained, splice_region_variant | 5/14 | ENST00000533608.7 | NP_997005.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXT2 | ENST00000533608.7 | c.937C>T | p.Gln313* | stop_gained, splice_region_variant | 5/14 | 1 | NM_207122.2 | ENSP00000431173.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250756Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135558
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460134Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 726444
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Exostoses, multiple, type 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | This sequence change creates a premature translational stop signal (p.Gln313*) in the EXT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EXT2 are known to be pathogenic (PMID: 10679937, 19810120). This variant is present in population databases (rs763718818, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with multiple osteochondromas (PMID: 16283885, 28849184). ClinVar contains an entry for this variant (Variation ID: 265134). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2021 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 17041877, 16283885, 33726816, 28849184) - |
EXT2-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 03, 2023 | The EXT2 c.937C>T variant is predicted to result in premature protein termination (p.Gln313*). This variant has been reported in individuals with multiple osteochondromas (Wuyts et al. 2005. PubMed ID: 16283885; Table S1, Jennes et al. 2009. PubMed ID: 19810120; described as c.1036C>T/p.Gln346X in Xu et al. 2017. PubMed ID: 28849184). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-44146532-C-T). Nonsense variants in EXT2 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at